[mailpoet_sector_follow]

US Broker Ratings

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Potential Upside of Over 120% Sparks Investor Interest

Recursion Pharmaceuticals, Inc. (RXRX), a pioneering entity in the biotechnology sector, has captured investor attention with the potential for a remarkable 120.36% upside, according to analyst..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring an 18% Upside Amidst Strong Revenue Growth

Bausch Health Companies Inc. (NYSE: BHC) is commanding attention in the healthcare sector with an intriguing blend of growth and potential upside. With its roots firmly..

Centessa Pharmaceuticals plc (CNTA) Investor Outlook: Navigating Biotech Potential Amidst Market Stability

For investors interested in the dynamic world of biotechnology, Centessa Pharmaceuticals plc (NASDAQ: CNTA) presents a unique opportunity. With a market capitalization of $6.27 billion, Centessa..

SS Innovations International (SSII) Stock Analysis: Unpacking the 86.67% Potential Upside

SS Innovations International Inc. (SSII), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to surgical..

PROCEPT BioRobotics (PRCT) Stock Analysis: Navigating Growth in the Medical Device Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is a notable player in the healthcare sector, specifically within the medical devices industry, with a focus on surgical robotics. Headquartered..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A 42% Upside Potential in the Biotechnology Sector

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a burgeoning player in the healthcare sector, is capturing the attention of investors with its promising potential upside of 42.26%. This..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a 111.57% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out in the biopharmaceutical sector with an exciting growth narrative, driven by its innovative approach to treating rare diseases. With..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Exploring a 152% Potential Upside in Biotech Innovations

Ascentage Pharma Group International (AAPG), a dynamic player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 152.15%. Headquartered in Suzhou,..

QuidelOrtho Corporation (QDEL): Investor Outlook on Growth Amidst Challenges and Opportunities

QuidelOrtho Corporation (NASDAQ: QDEL), a notable player in the healthcare sector’s medical devices industry, presents a mixed bag of opportunities and challenges for investors. With a..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: A Promising Outlook with 28% Potential Upside

Kiniksa Pharmaceuticals International (NASDAQ: KNSA) is making waves in the healthcare sector, particularly within the specialized field of drug manufacturing. With a focus on developing innovative..

Acadia Healthcare (ACHC) Stock Analysis: Investor Outlook Amid Behavioral Health Focus and 5% Upside Potential

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands at the forefront of the U.S. behavioral healthcare industry, offering an array of services through its extensive network of..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Navigating Stability with a 24.5% Return on Equity

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a noteworthy player in the healthcare sector, carving out a niche in the biotechnology industry with a focus on rare..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 70% Potential Upside in the Medical Devices Industry

Enovis Corporation (NYSE: ENOV), a notable player in the healthcare sector, specifically within the medical devices industry, is capturing investor interest with its impressive growth potential...

Disc Medicine, Inc. (IRON) Investor Outlook: Potential 29% Upside Ignites Interest

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors with a compelling potential upside of 29.24%, based on analyst ratings. This clinical-stage biopharmaceutical company,..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 39% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector, specializes in the development, manufacture, and marketing of medical devices used in vascular surgery...

Surgery Partners, Inc. (SGRY) Investor Outlook: Navigating a 16.84% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, is attracting attention from investors with its promising 16.84% potential upside. As a leading..

Privia Health Group, Inc. (PRVA) Stock Analysis: A 41% Potential Upside with Strong Buy Ratings

Privia Health Group, Inc. (NASDAQ: PRVA) is capturing investor attention with its robust growth potential in the healthcare sector. As a national physician-enablement company based in..

ICU Medical, Inc. (ICUI) Stock Analysis: Strong Buy Ratings and a 5.32% Potential Upside

For investors keen on the healthcare sector, ICU Medical, Inc. (NASDAQ: ICUI) presents a compelling opportunity. The company, with a market capitalization of $4.56 billion, is..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Genomics Pioneer with 10.28% Upside Potential

GeneDx Holdings Corp. (NASDAQ: WGS) stands as a notable player in the healthcare sector, specifically within the Diagnostics & Research industry. As a U.S.-based genomics company,..

CG Oncology, Inc. (CGON) Stock Analysis: A Potential 18.96% Upside in the Biotech Sector

Investors seeking opportunities in the biotechnology sector should pay close attention to CG Oncology, Inc. (NASDAQ: CGON). With a current market capitalization of $6.79 billion, this..

Search

Funds

UK Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds